BIOMARKER
QIAGEN OmicSoft and Biomedical Knowledge Base
Supporting Biomarker Discovery One Cell at a Time - Introduction to QIAGEN...
Single-cell gene expression analysis helps biologists and bioinformaticians reveal...
QIAGEN OmicSoft and Biomedical Knowledge Base
Drug Target and Biomarker Investigation using OmicSoft OncoLand
In this 90-minute training, attendees will learn how to use basic expression analysis...
QIAGEN OmicSoft and Biomedical Knowledge Base
Checkpoint inhibitors investigation in context of biomarkers, drug targets...
This training will focus on how QIAGEN Omicsoft Studio and IPA can be used to discover...
QIAGEN OmicSoft and Biomedical Knowledge Base
Drug treatment, toxicology and target safety assessment using QIAGEN IPA and...
In this 90-minute training, you’ll learn how to do drug treatment, toxicology and...
QIAGEN OmicSoft and Biomedical Knowledge Base
QIAGEN Biomedical KB-HD: data- and analytics-driven drug discovery
Ingenuity Pathway Analysis (IPA), currently cited in tens of thousands of publications...
QIAGEN OmicSoft and Biomedical Knowledge Base
Integrating deeply curated omics data with APIs for biomarkers and drug...
This webinar is for data scientists and bioinformaticians who need extensive...
Gene Variant Databases
Leveraging expert-curated knowledge from COSMIC and QIAGEN to avoid pitfalls,...
The cancer drug discovery landscape is shifting. While research continues to grow in...
QIAGEN OmicSoft and Biomedical Knowledge Base
Biomarker discovery, target validation, and variant identification using...
In this webinar, users will learn how to leverage solutions from QIAGEN Digital...
QIAGEN OmicSoft and Biomedical Knowledge Base
Target exploration and cell line selection for drug discovery
Cancer cell line models have been a cornerstone of cancer research for decades....
QIAGEN OmicSoft and Biomedical Knowledge Base
Mining curated knowledge graphs and validating with experimental datasets to...
In an era of near-limitless public experimental data but little standardization,...
QIAGEN OmicSoft and Biomedical Knowledge Base
Exploring pan-cancer immunomodulators for biomarker discovery and validation...
Cancer outcome is influenced by both the tumor microenvironment and host immune...
QIAGEN IPA
Cross-species comparison and validation for drug discovery and biomarker...
Some human studies may be unfeasible or unethical, making cross-species research...